An Evidence-Based Systematic Review of Active Hexose Correlated Compound (AHCC) by the Natural Standard Research Collaboration

REFERENCES

• Amenomori S, Fukatsu K, Murakoshi S, Yanagawa M, Mitsui T, Yokota H, Yashuhara H. Does AHCC supplementation prevent 5-FU-induced impairment of gut immunity? A pilot animal study. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G. Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions. J Appl Physiol. 2003;95(2):491–496.
   PubMed Web of Science ®Google Scholar
• Aviles H, Belay T, Vance M, Sun B, Sonnenfeld, G. Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions. J Appl.Physiol. 2004;97(4):1437–1444.
   PubMed Web of Science ®Google Scholar
• Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld, G. Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection. Am J Surg. 2008;195(4):537–545.
   PubMed Web of Science ®Google Scholar
• Aviles H, O'Donnell P, Sun B, Sonnenfeld, G. Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection. Surg Infect (Larchmt). 2006;7(6):527–535.
   PubMedGoogle Scholar
• Bach A, Ferrer A, Puig DM, Ahedo J, Chetri, C. Effects of supplementing a combination of nucleoforce® and AHCC to dairy calves prior weaning on respiratory afflictions and immune response during the postweaning period. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Badawi TA, Khalil NA, Abdelrahman AH, Aly ZH. Immunoprophylactic effect of active hexose correlated compound on normal and induced submandibular salivary gland neoplasm in Albino rats. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Bold-Erdene A, Baatamum A, Jigjidsuren, C. Efficacy of active hexose correlated compound (AHCC) in treatment of hepatocellular carcinoma patients at the National Cancer Center of Mongolia. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Burikhanov RB, Wakame K, Igarashi Y, Wang S, Matsuzaki, S. Suppressive effect of active hexose correlated compound (AHCC) on thymic apoptosis induced by dexamethasone in the rat. Endocr Regul. 2000;34(4):181–188.
   PubMedGoogle Scholar
• Cao Z, Lin W, Chen R, Chen X, Liao L, Ou, J. The preliminary study of AHCC freeze-dried powder and AHCC serum on proliferation and apoptosis of hepatoma cell line. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Cheadle WG, Peyton J, Aviles H, Sonnenfeld, G. The effect of active hexose correlated compound (AHCC) on the innate host immune response to chronic murine peritonitis. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Chutaputthi, A. Pilot study of AHCC on HBeAg Level in CHBeAg positive patients on long term anti-viral treatment. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa, W. Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. Asian Pac J Allergy Immunol. 2006;24(1):33–45.
   PubMed Web of Science ®Google Scholar
• Daddaoua A, Martinez-Plata E, Lopez-Posadas R, Vieites JM, Gonzalez M, Requena P, Zarzuelo A, Suarez MD, de Medina FS, Martinez-Augustin, O. Active hexose correlated compound acts as a prebiotic and is antiinflammatory in rats with hapten-induced colitis. J Nutr. 2007;137(5):1222–1228.
   PubMed Web of Science ®Google Scholar
• Daddaoua A, Martinez-Plata E, Ortega-Gonzalez M, Ocon B, Aranda CJ, Zarzuelo A, Suarez MD, de Medina FS, Martinez-Augustin, O. The nutritional supplement active hexose correlated compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-kappaB/MAPK activation. Food Chem. 2013;136(3–4):1288–1295.
   PubMed Web of Science ®Google Scholar
• Drannik AG, Kurchenko AI, Savchenko VS, Drannik GN. AHCC induces in vitro functional activity ofPBMC-derived mononuclear cells from subjects with recurring herpes simplex type 1 and 2 infections. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Du, J. Effect of AHCC for peripheral blood VEGF in hepatocarcinoma-inoculated mice. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Du, J. Anti-tumor Effects of AHCC in H22 tumor-bearing ICR mice and BALB/c nude mice. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Fujii H, Nishioka H, Wakame K, Sun, B. Nutritional food active hexose correlated xompound (AHCC) enhances resistance against bird flu. Jpn J Complimentary and Alt Med. 2007;4(2):37–39.
   Google Scholar
• Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts, A. Genotoxicity and subchronic toxicity evaluation of active hexose correlated compound (AHCC). Regul Toxicol Pharmacol. 2011;59(2):237–250.
   PubMed Web of Science ®Google Scholar
• Fuller R, Kenyon J. A review of AHCC and 1-3/1-613 glucan on natural killer cell activity in a series of cancer patients. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses. Cancer Immunol Immunother. 2006;55(10):1258–1266.
   PubMed Web of Science ®Google Scholar
• Garcia JJ, Bautista L, Bolas F, Fujii H, Torrado-Duran JJ. Effect of AHCC on the anthelmintic activity of Albendazole. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Gardner E. AHCC supplementation of energy-restricted mice may improve natural killer cell function during primary influenza infection. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Ghoneum M, Wimbley M, Salem F, McKlain A, Attallah N, Gill G. Immunomodulatory and anticancer effects of active hexose correlated compound (AHCC). Int J Immunother. 1995;11:23–28.
   Web of Science ®Google Scholar
• Ghonewn M. NK-immunomodulation by active hemicellulose compound (AHCC) in 17 cancer patients. Presented at the 2nd Meeting of the Society for Natural Immunity 1994.
   Google Scholar
• Haidari M, Zhang W, Chen, Z. Active hexose correlated compound (AHCC) inhibits disruption of endothelial adherens junction induced by high concentration of glucose. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Haidari M, Zhang W, Chen Z, Ganjehei L, Mortazavi A, Dixon R. AHCC attenuates cytokine-induced attachment of invasive cancer cells to endothelial cells. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011a.
   Google Scholar
• Haidari M, Zhang W, Chen Z, Ganjehei L, Mortazavi A, and Dixon, R. AHCC protects endothelial cells against disruption of adherens junction by pro-inflammatory stimuli [general lecture]. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011b.
   Google Scholar
• Hangai S, Yamaguchi T, Kuroda Y, Kogure Y, Iwase S. Exploratory clinical research on active hexose correlated compound (AHCC): effect of AHCC on patients with breast cancer treated with adjuvant chemotherapy. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Hayama K, Yamazaki M, Abe, S. Protective activity of combination of AHCC and UREX against murine vaginal candidiasis. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Hirata S, Takanari J, Wakame, K. Evaluation of AHCC for quality of life (QOL) as integrative medicine during treatment of advanced head and neck cancer patients. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Hirooka S, Yanagimoto H, Satoi S, Toyokawa H, Yamamoto T, Yui R, Yamaki S, Michiura T, Inoue K, Kwon, A. Effect of administration of AHCC in rat with subcutaneous tumor of pancreatic cancer cell. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Hirose A, Sato E, Fujii H, Sun B, Nishioka H, and Aruoma OI. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice. Toxicol Appl Pharmacol. 2007;222(2):152–158.
   PubMed Web of Science ®Google Scholar
• Hisajima T, Maruyama N, Funakoshi K, Abe, S. Effect of AHCC on the mucosal immune system of the mice with intestinal candidiasis. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Hong SJ, Chung BH, Kim JS, Lee MJ, Yoon S, Oh HY, Lee EJ, Lim HG, Buxiang, S. The effects of GAC on the biochemical profiles and quality of life of metastatic prostate cancer patients. Korean J Urol. 2006;47(5):467–474.
   Google Scholar
• Hunter RJ, Fujii H, Wakame K, Gaikwad A, Wolf JK, Smith JA. Evaluation of active hexose correlated compound (AHCC) in combination with pegylated liposomal doxorubicin for treatment of ovarian cancer. Int J Appl Res Nat Prod. 2011;4(3):6–14.
   Google Scholar
• Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin.Oncol. 2005;23(12):2645–2654.
   Google Scholar
• Ikeda T, Ishibashi H, Fujisaki R, Yamazaki M, Wakame K, Kosuna K, Yamaguchi H, Ono Y, Abe S. [Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice]. Nihon Ishinkin Gakkai Zasshi. 2003;44(2):127–131.
   PubMedGoogle Scholar
• Ishibashi H, Ikeda T, Tansho S, Ono Y, Yamazaki M, Sato A, Yamaoka K, Yamaguchi H, Abe S. [Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal opportunistic infections in mice]. Yakugaku Zasshi. 2000;120(8):715–719.
   PubMed Web of Science ®Google Scholar
• Ishizuka R, Fujii H, Miura T, Fukuchi Y, Tajima K. Therapeutic gaps between the evidence based medicine (EBM) and cancer patients in the advanced stage or recurrence: review of cancer therapy with AHCC and GCP under individual EBMfrom the long-term follow-up over 11 years for cancer of the lung and the Brea. Presented at the 17th International Congress on Nutrition and Integrative Medicine (ICNIM) 2009.
   Google Scholar
• Ishizuka R, Fujii H, Miura T, Fukuchi Y, Tajima K. Review of cancer therapy with AHCC® and GCP®; The long-term follow-up over 12 years for stage IV (M1) cancer of the lung and the breast. Int J Integr Med. 2010;2(1):98–111.
   Google Scholar
• Ishizuka R, Fujii H, Miura T, Fukuchi Y, Tajima K. Personalized cancer therapy with AHCC and GCP; The long-term follow-up over 16 years for stage IV (Ml) of non-small cell lung cancer (NSCLC). Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Iwamoto M. Effects of AHCC on diabetes by clinical and basic researches. The 2nd Annual Meeting of the Japanese Society for Alternative Medicine & Treatment 1999.
   Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Jiang S, Nakano T, Nishizawa M, Kimura T. Effect of AHCC on IFN-al antisense RNA and mRNA expression levels in the respiratory tract of influenza virus AlPR/8/34-infected guinea pigs. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Karkow A, Karkow F. AHCC: a personal experience. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Kawaguchi Y. Improved survival of patients with gastric cancer or colon cancer when treated with active hexose correlated compound (AHCC): effect of AHCC on digestive system cancer. Nat Med J. 2009;1(1):1–6.
   Google Scholar
• Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 2000;5(1):4–27.
   PubMedGoogle Scholar
• Kim J. The effect of AHCC in non-viral, chronic and abnormal liver function condition: a randomized, double-blind, placebo-control study. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Kulkarni, A. Dietary AHCC in acute gut injury model. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Kulkarni A, Malya RR, Karkow F. Targeted immunonutrition for chronic non-communicable diseases (NCDs) in resource limited settings. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Kurokawa, T. Use of AHCC in multimodality therapy against advanced or terminal cancer. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Lee WW, Kang I. Investigating the effect of AHCC and a-glucan on IL-IP and IL-6 production from human monocytes. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Lee WW, Lee N, Fujii H, Kang, I. Active hexose correlated compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1beta production from monocytes in humans. Cell Immunol. 2012;275(1–2):19–23.
   PubMed Web of Science ®Google Scholar
• Lee WW, Shin MS, Kang, I. AHCC induces production ofIL-17 from CD4+ T cells via stimulating monocytes in humans. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Luo A, Zhang K, Wakame K, Kulkarni, A. Dietary active hexose correlated compound (AHCC) decreases ischemial reperfusion injury [general lecture]. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Mach CM, Fugii H, Wakame K, Smith J. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents. J Soc Integr Oncol. 2008;6(3):105–109.
   PubMedGoogle Scholar
• Maeno H, Takanari J, Wakame K. Effect of AHCC for palliative care in horne care patients with terminal cancer. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Masuyama T, Mizuishi Y, Moriyama A, Takeshita K, Takahashi T, Kuwabara M. Application of new immunotherapy using AHCC for animal disease. Presented at the 8th International Congress on Nutrition and Integrative Medicine (ICNIM) 2000.
   Google Scholar
• Matsui K, Kawaguchi Y, Ozaki T, Tokuhara K, Tanaka H, Kaibori M, Matsui Y, Kamiyama Y, Wakame K, Miura T, Nishizawa M, Okumura, T. Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes. JPEN J Parenter Enteral Nutr. 2007;31(5):373–380.
   PubMed Web of Science ®Google Scholar
• Matsui K, Ozaki T, Oishi M, Tanaka Y, Kaibori M, Nishizawa M, Okumura T, Kwon AH. Active hexose correlated compound inhibits the expression of proinflammatory biomarker iNOS in hepatocytes. Eur Surg Res. 2011;47(4):274–283.
   PubMed Web of Science ®Google Scholar
• Matsui Y, Kamiyama Y. Retrospective study in breast cancer patients supplemented with AHCC. Int J Integr Oncol. 2009;3(2):12–16.
   Google Scholar
• Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y. Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study. J Hepatol. 2002;37(1):78–86.
   PubMed Web of Science ®Google Scholar
• Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa, M. Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma. Anticancer Drugs. 1998;9(4):343–350.
   PubMed Web of Science ®Google Scholar
• Matuo A, Yamada M, Nakayama K, Sudou K, Yamada K, Nakagawa H, Takahasi T, Takeshita K, Kuwabara M. Application of the new immunotherapy using AHCC for animal disease I. Presented at the 8th International Congress on Nutrition and Integrative Medicine (ICNIM) 2000.
   Google Scholar
• Miyaji T, Hangai S, Kawaguchi T, Kogure Y, and Yamaguchi T. Exploratory clinical research on active hexose correlated compound in the adjuvant chemotherapy of breast cancer. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Mukoda S, Kosuna K, Okada F. Reduction of side affects of anticancer drugs by active hexose correlated compound (AHCC). Proceedings of the American Association for Cancer Research 1999;40.
   Google Scholar
• Nakamoto D, Shigama K, Nishioka H, Fujii H. Alleviating effect of AHCC for gemcitabine-induced hematopoietic toxicity in mice [poster session]. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Nishioka H. Preventive effect of AHCC for avian influenza virus. Presented at the 15th International Symposium of the AHCC Research Association 2007.
   Google Scholar
• Nishioka H, Wakame K. Ameliorative effect of AHCC for anticancer drug-induced side effects [general lecture]. Presented at the 16th International Congress on Nutrition and Integrative Medicine (ICNIM) 2008.
   Google Scholar
• Nishizawa M, Okuyama T, Yoshigai E, Okumura T. AHCC suppresses expression of cytokine/chemokine mRNA in rat hepatocytes. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Nogusa S, Gerbino J, Ritz BW. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice. Nutr Res. 2009;29(2):139–143.
   PubMed Web of Science ®Google Scholar
• Nomura T, Adachi S, Ryo H, Kikuya R, Hatanaka E, Tokita Y, Nakajima H, Hongyo T, Parida DK. Prevention of cancer and malformation by active hexose correlated compound (AHCC) in mice and humans. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Nomura T, Kikuya R, Adachi S, Ryo H, Hatanaka E, Kaji M, Yasuda K, Nakajima H, Hongyo T, Parida DK, Wakame, K. Prevention of cancer and radiation induced disorders by active hexose correlated compound, AHCC in mice and humans. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Nomura T, Nakajima H, Hongyo T, Kikuya R, Adachi S, Ryo H, Tokita Y, Eiko H, Yoshida N, Parida DK, Wakame, K. Inhibition of radiation induced late effects (congenital malformations and leukemia) by active hexose correlated compound, AHCC in mice. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Ocon B, Anzola A, Ortega M, Zarzuelo A, Suarez MD, de Medina FS, and Augustin OM. Active hexose correlated compound and Bifidobacterium longum exert symbiotic effects in experimental colitis. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Ocon B, Anzola A, Ortega-Gonzalez M, Zarzuelo A, Suarez MD, Sanchez de, Medina F, Martinez-Augustin O. Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Eur J Nutr. 2013;52(2): 457–466.
   PubMed Web of Science ®Google Scholar
• Okumura T, Matsumyia M, Araki Y, Matsuura T, Kaibori M, Kwon A, Nishioka H, Shigama K, Nakamoto D, Yoshigai E, Hara T, Nishizawa M. Effect of AHCC on the induction of iNOS and proinflammatory cytokines in LPS-treated mice. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Okuyama T, Yoshigai E, Okumura T, Ikeya Y, Nishizawa, M. Parallel assessment of effects of AHCC on longevity of the nematode C. elegans and nitric oxide production in rat hepatocytes. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Parida DK, Wakame K, Nomura T. Integrating complimentary and alternative medicine in form of active hexose correlated compound (AHCC) in the management of head & neck cancer patients. Int J Clin Med. 2011;2:588–592.
   Google Scholar
• Ritz BW. Supplementation with active hexose correlated compound increases survival following infectious challenge in mice. Nutr Rev. 2008;66(9):526–531.
   PubMed Web of Science ®Google Scholar
• Ritz BW, Nogusa S, Ackerman EA, Gardner EM. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr. 2006;136(11):2868–2873.
   PubMed Web of Science ®Google Scholar
• Roman BE, Beli E, Duriancik DM, Gardner EM. Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res. 2013;33(1):12–17.
   PubMed Web of Science ®Google Scholar
• Sakaguchi T, Ishizaki M, Kaibori M, Matsui K, Hirooka S, Tsuda T, Matsushima H, Matsui Y, Kwon, A. Complete response of advanced hepatocellular carcinoma using AHCC in multimodality therapy. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Sakaue M, Maeda K, Igura T, Kitagawa T, Sumi R, Hirai K, Kondo K, Ito T. Phase I/II clinical study of AHCC as adverse effect reducer in cancer patients with chemotherapy (the 3rd report). Presented at the 17th AHCC Research Association 2009.
   Google Scholar
• Sanchez de Medina F, Plata EM, Romero-Calvo I, Ortega M, Gonzalez R, Daddaoua A, Martinez-Moya P, Zarzuelo A, Suarez MD, Martinez-Augustin O. Correlated compound exerts immunomodulatory effects and induces differentiation in several intestinal cell types that are independent on their prebiotic actions. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Sasaki S, Okawa H, Nishioka H. Activation of macrophages and lymphocytes by AHCC-containing liquid product. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Sato K, Ohashi S, Tanaka Y, Miki H, Oishi M, Tokuhara K, Kaibori T, Okumura T, Nishizawa M, Kwon A. Occurrence of hydrophilic hepato-protective compounds in AHCC in addition to adenosine. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Shah SK, Walker PA, Moore-Olufemi SD, Sundaresan A, Kulkarni AD, Andrassy RJ. An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient. JPEN J Parenter Enteral Nutr. 2011;35(4):449–458.
   PubMed Web of Science ®Google Scholar
• Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice. J Exp Ther Oncol. 2009;8(1):43–51.
   PubMedGoogle Scholar
• Smith JA, Gaikwad A, Jaffari M, Frumovitz M, Meyer L. Evaluation of active hexose correlated compound (AHCC) for the prevention or delay of tumor growth in human cervical cancer xenograft model. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Smith JA, Hunter RJ, Fujii H, Wakame K, Wolf, J. Defining synergistic activity of the combination of active hexose correlated compound (AHCC) with liposomal doxorubicin (Doxil). Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Sonnenfeld G. Use of animal models for space flight physiology studies, with special focus on the immune system. Gravit Space Biol Bull. 2005;18(2):31–35.
   PubMedGoogle Scholar
• Sonnenfeld G, Peyton J, Cheadle W, Fujii H, and Sun, B. Effects of active hexose correlated compound (AHCC) on stress hormones and immune parameters. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Spierings EL, Fujii H, Sun B, Walshe T. A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. J Nutr. Sci Vitaminol (Tokyo). 2007;53(6):536–539.
   PubMed Web of Science ®Google Scholar
• Sula J. Our experience in measuring the increased activity of Properdin in patients with cancer after using AHCC for six months. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Sumiyoshi Y, Hashine K, Kakehi Y, Yoshimura K, Satou T, Kuruma H, Namiki S, Shinohara N. Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study. Jpn J Clin Oncol. 2010;40(10):967–972.
   PubMed Web of Science ®Google Scholar
• Sun B, Mukoda T, Miura T, Fujii H, Yuan L, White R. Anti-tumor effects of genistein combined polysaccharide (GCP) and active hexose correlated compound (AHCC). Transl Biother. 2001;15(3):379–382.
   Google Scholar
• Sun B, Wakame K, Mukoda T, Toyoshima A, Kanazawa T, Kosuna K. Preventive effects of AHCC on carbon tetrachloride induced liver injury in mice. Nat Med. 1997;51(4):310–315.
   Google Scholar
• Sun B, Wakame K, Sato E, Nishioka H, Aruoma OI, Fujii H. The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents. Cancer Epidemiol. 2009;33(3–4):293–299.
   PubMed Web of Science ®Google Scholar
• Sundaresan A, Wakame K, Kulkarni AD. AHCC positively regulates liver metabolism by diminishing oxidative stress and protects the heart by increasing liver trafficking of LDL. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Szalus N. AHCC for treatment of Idiopathic thrombocytopenic purpura in 11 year-old girl—a case report. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Szalus N, Budlewski T. AHCC's impact on the immunological system and adverse effects in patients with disseminated neuroendocrine tumors (NETs) treated with radioisotope preparation (90Y-DOTA-TATE). Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Takahashi T, Shinobu K, Nakayam K, Yamada M, Takeshita K, Yamada K, Kuwabara M. Augmentation of canine cellular immune response by administration of AHCC [general lecture]. Presented at the 8th International Congress on Nutrition and Integrative Medicine (ICNIM) 2000.
   Google Scholar
• Tanaka Y, Ohashi S, Sato K, Miki H, Oishi M, Tokuhara K, Kaibori M, Okumura T, Nishizawa M, Kwon AH. Adenosine, a Hepato-protective compound in AHCC. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Terada M, Kitadate K, Nanbo Y, Sato, F. Effects of AHCC on hematological parameters for immunity and stress in thoroughbred horses. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y. Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. Nutr Cancer. 2008;60(5):643–651.
   PubMed Web of Science ®Google Scholar
• Thaiudom S, Piyaniran W, Chutaputthi A. A study of the efficacy of active hexose correlated compound (AHCC) in the treatment of chronic hepatitis C patients at Phramongkutklao Hospital. The Med. News (Thailand). 2010;325:13–16.
   Google Scholar
• Tolentino R, Lola C, Santos C, Homma K, de Villa R. AHCC effects in breast cancer prevention, screening, diagnosis and management. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Turner J, Chaudhary U. Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate cancer. Anticancer Drugs. 2009;20(3):215–216.
   PubMed Web of Science ®Google Scholar
• Uno K, Kosuna K, Sun B, Fujii H, Wakame K, Chikumaru S, Hosokawa G, Ueda Y. Active hexose correlated compound (AHCC) improves immunological parameters and performance status of patients with solid tumors. Biotherapy. 2000;14(3):303–309.
   Google Scholar
• Urushima H, Matsumoto M, Hayashi N, Maeda K, Tamaki Y, Noguchi S, Ito T. Randomized, placebo-controlled trial (RCT) of AHCC for the reduction of side effects in breast cancer chemotherapy. Presented at the 19th International Congress on Nutrition and Integrative Medicine (ICNIM) 2011.
   Google Scholar
• Wakame K. Protective effects of active hexose correlated compound (AHCC) on the onset of diabetes induced by Streptozotocin in the rat. Biomed Res. 1999;20(3):145–152.
   Web of Science ®Google Scholar
• Waki H, Miyazaki S, Hisajima, T. The effects of AHCC on the autonomic nervous function. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar
• Wang S, Ichimura K, Wakame K. Preventive effects of active hexose correlated compound (AHCC) on oxidative stress induced by ferric nitrilotriacetate in the rat. Dokkyo J Med Sci. 2001a;28(2–3):745–752.
   Google Scholar
• Wang S, Wakame K, Igarashi Y, Kosuna K, Matsuzaki S. AHCC on immobilization stress in the rat: beneficial effects of active hexose correlated compound. Dokkyo J Med Sci. 2001b;28(1):559–565.
   Google Scholar
• Wang S, Welte T, Fang H, Chang GJ, Born WK, O'Brien RL, Sun B, Fujii H, Kosuna K, Wang T. Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice. J Nutr. 2009;139(3):598–602.
   PubMed Web of Science ®Google Scholar
• Yagami K, Nishizawa M, Shirota T, Shigeru Y, Yagasaki T. AHCC maintains the osteoblastic differentiation of mesenchymal stem cells, inhibiting NO production by the inflammatory cytokines. Presented at the 18th International Congress on Nutrition and Integrative Medicine (ICNIM) 2010.
   Google Scholar
• Yagita A, Maruyama S, Wakasugi S, Sukegawa Y. H-2 haplotype-dependent serum IL-12 production in tumor-bearing mice treated with various mycelial extracts. In Vivo. 2002;16(1):49–54.
   PubMed Web of Science ®Google Scholar
• Yanagimoto H, Satoi S, Toyokawa S, Yamamoto T, Hirooka S, Yamao J, Araki H, Matsui Y, Kwon, A. The beneficial effect of active hexose correlated compound (AHCC), a health food component, in patients with pancreatic or biliary tract cancer who underwent chemotherapy. Presented at the 40th APA (American Pancreatic Association) 2009.
   Google Scholar
• Ye SF, Ichimura K, Wakame K, Ohe M. Suppressive effects of active hexose correlated compound on the increased activity of hepatic and renal ornithine decarboxylase induced by oxidative stress. Life Sci. 2003;74(5):593–602.
   PubMed Web of Science ®Google Scholar
• Ye SF, Wakame K, Ichimura K, Matsuzaki S. Amelioration by active hexose correlated compound of endocrine disturbances induced by oxidative stress in the rat. Endocr Regul. 2004;38(1):7–13.
   PubMedGoogle Scholar
• Yin Z, Fujii H, Walshe T. Effects of active hexose correlated compound on frequency of CD4+ and CD8+ T cells producing interferon-gamma and/or tumor necrosis factor-alpha in healthy adults. Hum Immunol. 2010;71(12):1187–1190.
   PubMed Web of Science ®Google Scholar
• Zhang XH, Nishioka H, Fujii H. Inhibitory effect of AHCC and GCP on upregulated CD133 and Nestin expressions induced by norepinephrine in C6 glioma cells. Presented at the 20th International Congress on Nutrition and Integrative Medicine (ICNIM) 2012.
   Google Scholar